Tuesday, December 17, 2019 8:47:20 AM
Hitchman Brings Deep Experience in Product Development, Commercialization and Operations
SAN DIEGO, Dec. 17, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that Tim Hitchman, PhD, has joined the Company as Director of Operations.
“We are very pleased to welcome Dr. Tim Hitchman to the CV Sciences team,” said Joseph Dowling, Chief Executive Officer of CV Sciences. “Tim brings a wealth of experience in leading product development and commercialization, as well as in operational roles in hemp & cannabis, food ingredients, agricultural processing & industrial biotechnology. He will play an integral role in enhancing and driving our operations to advance product innovation and commercialization. Tim’s expertise across multiple key functional areas and industries will further accelerate our innovation pipeline and growth.”
“CV Sciences is a hemp CBD pioneer, leads the market in hemp CBD products and is a proven leader in science, regulatory and compliance,” said Dr. Hitchman. “I am excited to join the CV Sciences team and leverage my experience to help the Company capitalize on the long-term opportunity in the growing hemp CBD industry through continued product innovation and differentiation based on the scientific rigor CV Sciences has long deployed.”
Most recently, from late 2018, Dr. Hitchman served as Chief Technology Officer at Tradewinds Holding LLC, a start- up cannabis oils production company. In this role, he led development and scaling of an innovative “warm-ethanol” extraction and production process, and he was responsible for site operations.
Earlier in 2018, Dr. Hitchman was engaged as a Project Director for the DSM Nutritional Products Group, where he drove a change in business focus and operations to develop and deliver consumer-led product concepts. Prior to 2018, Dr. Hitchman served in a variety of roles at DSM, most recently as Innovation Director Growth Platforms, where he led development of numerous strategic products targeting new growth opportunities, including launch of two new enzyme products.
Prior to DSM, Dr. Hitchman served in a variety of roles at Verenium Corporation (formerly Diversa Corporation) from 2001-2012, where he built the Oils & Fats Enzymes business from launch of the first product in 2008, with responsibility for sales & marketing, as well as oversight of production development. Before taking on this commercial role, he had leadership roles in the Verenium R&D organization managing strategic partnerships with Bunge and Givaudan and leading development of several products from concept to commercialization.
Dr. Hitchman earned a BA in Chemistry from Oxford University and a PhD in Bio-Organic Chemistry from Bristol University, both in the UK.
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:54:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:28:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
FEATURED Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • Sep 9, 2024 9:34 AM
North Bay Resources Commences Gold Shipments, Fran Gold Project, British Columbia; Enters Taber Gold Mine JV, Sierra County, California • NBRI • Sep 9, 2024 9:15 AM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM